R. Bell
Impact in
- Oncology top 1%
- Bone health and treatments
- Cancer Diagnosis and Treatment
-
- Bone and Joint Diseases
Papers in
- Co-authors
- M. D. Gwynne (1 shared paper)Hugo Jachmann (5 shared papers)John J. Seaman (2 shared papers)J.J. Body (2 shared papers)Jeremy K. Hon (1 shared paper)Ehtesham Abdi (1 shared paper)F. Yunus (1 shared paper)Pierre Major (1 shared paper)
- Journals
- Pancreas (8 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (3 papers)Cancer Research (2 papers)Nature (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
R. Bell
65 papers receiving 2.9k citations
R. Bell's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 1.6k
- Orthopedics and Sports Medicine 345
- Hematology 324
- Ecology 765
- Nature and Landscape Conservation 330
Countries citing papers authored by R. Bell
This map shows the geographic impact of R. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bell more than expected).
Fields of papers citing papers by R. Bell
This network shows the impact of papers produced by R. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bell. The network helps show where R. Bell may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Bell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials Hit paper breakdown → | 2001 | 589 |
| 2 | Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. Hit paper breakdown → | 1998 | 512 |
| 3 | 1982 | 254 | |
| 4 | 2004 | 249 | |
| 5 | 1968 | 211 | |
| 6 | 1990 | 172 | |
| 7 | 2010 | 171 | |
| 8 | 1985 | 105 | |
| 9 | 2011 | 98 | |
| 10 | 2008 | 76 | |
| 11 | 1967 | 69 | |
| 12 | 1984 | 59 | |
| 13 | Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. | 1997 | 49 |
| 14 | Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas. | 1993 | 48 |
| 15 | 2018 | 39 | |
| 16 | 1994 | 35 | |
| 17 | 2012 | 33 | |
| 18 | 1969 | 33 | |
| 19 | 2007 | 30 | |
| 20 | 1979 | 27 |
About R. Bell
R. Bell is a scholar working on Oncology, Ecology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 67 papers that have together received 3.2k indexed citations. Recurring topics across this work include Wildlife Ecology and Conservation (12 papers), Bone health and treatments (9 papers), HER2/EGFR in Cancer Research (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Breast Cancer Treatment Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Rangeland Management and Livestock Ecology (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (1.6k citations), Orthopedics and Sports Medicine (345 citations), Hematology (324 citations), Ecology (765 citations) and Nature and Landscape Conservation (330 citations). R. Bell has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include M. D. Gwynne, Hugo Jachmann, John J. Seaman, J.J. Body, Jeremy K. Hon, Ehtesham Abdi, F. Yunus, Pierre Major, Alain Lortholary and Erhard Quebe‐Fehling. Their work appears in journals such as Pancreas, Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.